Table_4_Colistin Resistant A. baumannii: Genomic and Transcriptomic Traits Acquired Under Colistin Therapy.XLSX by Viviana Cafiso (188805)

“…Notably we recovered, for the first time, lpxC and lpxD nsSNPs previously described only in “in-vitro” mutants and associated with colistin resistance in a clinical COL-R Ab. …”

Table_8_Colistin Resistant A. baumannii: Genomic and Transcriptomic Traits Acquired Under Colistin Therapy.XLSX by Viviana Cafiso (188805)

“…Notably we recovered, for the first time, lpxC and lpxD nsSNPs previously described only in “in-vitro” mutants and associated with colistin resistance in a clinical COL-R Ab. …”

Image_3_Colistin Resistant A. baumannii: Genomic and Transcriptomic Traits Acquired Under Colistin Therapy.JPEG by Viviana Cafiso (188805)

“…Notably we recovered, for the first time, lpxC and lpxD nsSNPs previously described only in “in-vitro” mutants and associated with colistin resistance in a clinical COL-R Ab. …”

Table_9_Colistin Resistant A. baumannii: Genomic and Transcriptomic Traits Acquired Under Colistin Therapy.XLSX by Viviana Cafiso (188805)

“…Notably we recovered, for the first time, lpxC and lpxD nsSNPs previously described only in “in-vitro” mutants and associated with colistin resistance in a clinical COL-R Ab. …”

Table_2_Colistin Resistant A. baumannii: Genomic and Transcriptomic Traits Acquired Under Colistin Therapy.DOCX by Viviana Cafiso (188805)

“…Notably we recovered, for the first time, lpxC and lpxD nsSNPs previously described only in “in-vitro” mutants and associated with colistin resistance in a clinical COL-R Ab. …”

Image_1_Colistin Resistant A. baumannii: Genomic and Transcriptomic Traits Acquired Under Colistin Therapy.JPEG by Viviana Cafiso (188805)

“…Notably we recovered, for the first time, lpxC and lpxD nsSNPs previously described only in “in-vitro” mutants and associated with colistin resistance in a clinical COL-R Ab. …”

Table_6_Colistin Resistant A. baumannii: Genomic and Transcriptomic Traits Acquired Under Colistin Therapy.XLSX by Viviana Cafiso (188805)

“…Notably we recovered, for the first time, lpxC and lpxD nsSNPs previously described only in “in-vitro” mutants and associated with colistin resistance in a clinical COL-R Ab. …”

Table_10_Colistin Resistant A. baumannii: Genomic and Transcriptomic Traits Acquired Under Colistin Therapy.XLSX by Viviana Cafiso (188805)

“…Notably we recovered, for the first time, lpxC and lpxD nsSNPs previously described only in “in-vitro” mutants and associated with colistin resistance in a clinical COL-R Ab. …”

Table_11_Colistin Resistant A. baumannii: Genomic and Transcriptomic Traits Acquired Under Colistin Therapy.XLSX by Viviana Cafiso (188805)

“…Notably we recovered, for the first time, lpxC and lpxD nsSNPs previously described only in “in-vitro” mutants and associated with colistin resistance in a clinical COL-R Ab. …”

(A) Schematic presentation of the human AID protein sequence along with the positions of the lysine residues mutated in the various constructs by Said Aoufouchi (49316)

“…Protein extracts were analyzed by immunoblotting with anti-AID. PARP (116 kD) was used as loading control. (C) BL2 cell clones stably expressing either WT-AID-EGFP (WT), mutNES-AID-EGFP (mutNES), a lysineless mutant of AID (Kzero), or the four other AID-EGFP lysine mutants depicted in A were transiently transfected with an HA-tagged ubiquitin-expressing vector and either left untreated (top) or incubated with both LMB and MG132 for 5 h (bottom). …”

Fast-slow decomposition of the model dynamics when the V0_V excitatory pathways are deleted. by Yaroslav I. Molkov (542831)

Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer’s Agents: Synthesis and Biological Evaluation by Mahesh Shidore (2827802)

“…Furthermore, compound <b>44</b> demonstrated in vivo neuroprotection by decreasing Aβ_1–42-induced toxicity by attenuating abnormal levels of Aβ_1–42, <i>p</i>-Tau, cleaved caspase-3, and cleaved PARP proteins. …”

Structural bioinformatics analysis of the crystallised CMT variants. by Aleksi Sutinen (10039145)

Oleic acid (OA) leads to the strong phosphorylation of FAK and AKT in ALDH^high cells, resulting in high proliferation and migration. by Hoe Suk Kim (107279)

“…<p>(A) Representative Western blot of the phosphorylation of FAK, AKT and ERK1/2 in ALDH^high cells and ALDH^low cells treated with OA. …”

Supplementary file 1_Transcriptome-wide N6-methyladenosinem modifications analysis of chicken cecum in responding to Campylobacter jejuni inoculation.zip by Yanan Zhao (3132906)

“…</p>Results<p>In the S group, the level of proinflammatory cytokines (IL-8, IL-1β, IL-18, TNF-α, IL-17A) and global RNA methylation were significantly decreased (P < 0.05). …”

Binding analysis of amino acids and their derivatives to T1r2a/T1r3LBD using differential scanning fluorimetry. by Hikaru Ishida (18239420)

Phylogenetic analyses. by Aleksi Sutinen (10039145)

Aggregation index (AI, %) and disaggregation threshold (γ at dISCmin, 1/sec) during weight reduction protocols. by Woo Hwi Yang (723342)

Sinupret is a robust activator of CFTR-mediated and calcium-activated Cl^- secretion. by Shaoyan Zhang (363713)

“…Summary data for Sinupret-stimulated ΔI_SC in WT MNSE, CFTR^−/− MNSE and HSNE (D). Sinupret significantly increased ΔI_SC (in µA/cm²)when compared to controls in both WT (20.7+/−0.9 vs. 5.6+/−0.9, p<0.05) and CFTR^−/− MNSE (ΔI_SC in µA/cm², 10.1+/−1.0 vs. 0.9+/−0.3, p<0.05). …”

<i>Arabidopsis</i> PEX19 is farnesylated. by Margaret M. McDonnell (2175666)

“…(D) HA-PEX19 expression decreases farnesylation of endogenous PEX19. …”